XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 100 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $586 | +78.7% | 315,487 | +151.5% | 0.00% | – |
Q2 2023 | $328 | -30.4% | 125,438 | -56.7% | 0.00% | -100.0% |
Q1 2023 | $471 | +2.4% | 289,450 | -16.4% | 0.00% | 0.0% |
Q4 2022 | $460 | -99.9% | 346,382 | -15.0% | 0.00% | 0.0% |
Q3 2022 | $635,000 | -21.3% | 407,609 | -22.3% | 0.00% | 0.0% |
Q2 2022 | $807,000 | -86.6% | 524,294 | -77.7% | 0.00% | -85.7% |
Q1 2022 | $6,022,000 | -17.1% | 2,352,599 | -5.2% | 0.01% | -12.5% |
Q4 2021 | $7,268,000 | – | 2,480,675 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $10,493,971 | 39.87% |
Stonepine Capital Management, LLC | 5,915,372 | $11,002,592 | 3.66% |
MPM BioImpact LLC | 3,987,967 | $7,417,619 | 1.98% |
SINECERA CAPITAL, LLC | 253,101 | $470,768 | 0.63% |
Opaleye Management Inc. | 390,000 | $725,400 | 0.24% |
Alpine Global Management, LLC | 300,000 | $558,000 | 0.14% |
DELTEC ASSET MANAGEMENT LLC | 315,246 | $586,358 | 0.13% |
Redmile Group, LLC | 1,046,587 | $1,946,652 | 0.09% |
GSA CAPITAL PARTNERS LLP | 381,231 | $709 | 0.06% |
Soleus Capital Management, L.P. | 304,083 | $565,594 | 0.05% |